Citation

88 FR 88401

Canonical document for this Federal Register citation.

Development of Monoclonal Antibody Products Targeting SARS-CoV-2 for Emergency Use Authorization; Guidance for Industry; Availability Thursday, December 21, 2023 88 FR 88401